期刊文献+

LY294002联合顺铂对脑胶质瘤U87细胞株增殖的影响 被引量:1

Effect of LY294002 combined with CDDP on proliferation in glioma U87 cells in vitro
下载PDF
导出
摘要 目的体外观察磷酸肌醇-3激酶(PI3K)特异性抑制剂LY294002与顺铂(CDDP)联合对人脑胶质瘤U87细胞株增殖的抑制作用。方法采用细胞毒实验(MTT)法、流式细胞术(FCM)检测LY294002单独或联合CDDP对人脑胶质瘤U87细胞增殖的抑制作用,并观察细胞形态学变化。结果 LY294002与CDDP均能抑制U87细胞生长,呈剂量依赖性,两者联合有协同效应。当CDDP为0.625μg/mL和LY294002为5μmol/L时达到最大协同作用(Q=1.21),FCM检测细胞被阻滞在G1期,S期细胞比例减少,差异有统计学意义(P<0.01)。结论 LY294002能有效提高神经胶质瘤U87细胞对CDDP的敏感性,本研究为两种化疗药物在临床上的联合应用提供了理论依据。 Objective To investigate the effects of LY294002 and CDDPiamycin(CDDP) on proliferation of glioma cancer cell line U87.Methods MTT assay was used to examine the inhibition rate cell growth when cells were treated at various concentrations of LY294002 and CDDP alone or combination.Cell cycle and apoptosis rate of U87 cells were detected by flow cytometry(FCM) after using drugs.Optic microscope was used to detect the morphological changes of U87 cells.Results Both LY294002 and CDDP exhibited a dose dependent inhibitory effect on the proliferation of U87 cells.The combination of LY294002 and CDDP exerted a synergistic effect on U87 cell growth inhibition.LY294002 in the concentration of 5 μmol/L and CDDP in the concentration of 0.625 μg/mL interaction was the most synergistic(Q=1.21).Combined treatment group raised U87 cells′apoptosis and induced G1 phase arrest compare with single drug treatment group(P0.01).Conclusion LY294002 could effectively induce U87 sensitivity to CDDP.And this conclusion provides theoretical basis for the conbined clinical use of LY294002 and CDDP.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第35期3692-3694,F0002,共4页 Chongqing medicine
基金 宜昌市科技基金资助项目(A01301-10)
关键词 神经胶质瘤 药物疗法 顺铂 LY294002 增殖抑制 glioma drug therapy cisplatin LY294002 growth inhibiting
  • 相关文献

参考文献13

二级参考文献38

  • 1张献东,韩永军,王东升.紫杉醇联合顺铂治疗晚期非小细胞肺癌的临床研究[J].实用诊断与治疗杂志,2006,20(2):120-121. 被引量:8
  • 2刘民锋,余险峰,郭伟,左石,罗剑,徐立宁,邹声泉.LY294002对胆管癌细胞化疗增敏作用的探讨[J].中国肿瘤临床,2006,33(11):611-613. 被引量:4
  • 3袁中玉,管忠震,周中梅,夏奕,黄万钟,杨秀丽.53例肺外小细胞癌的临床分析[J].癌症,2006,25(9):1131-1133. 被引量:12
  • 4李献文,金建华,王芳,陆文斌,顾小燕,张华,杨玉薇.多西紫杉醇周疗法加卡铂治疗晚期非小细胞肺癌的疗效[J].临床肺科杂志,2007,12(6):539-540. 被引量:7
  • 5Wesffall SD, Skinner MK. Inhibition of phosphatidylinositol 3 - ki- nase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment [ J ] . Mol Cancer Ther, 2005; 4: 1764 - 1771.
  • 6Liang J, Ge F, Guo C, et al. Inhibition of PI3K/Akt partially leads to the inhibition of PrP ( C ) - induced drug resistance in gastric cancer cells [ J ]. FEBS J, 2009 ;276 : 685 - 694.
  • 7Notarbartolo M, Poma P, Perri D,et aL Antltumor effects of eureu- min, alone or in combination with cisplatin or doxorubiein, on hu- man hepatic cancer cells. Analysis of their possible relationship to changes in NF - kappaB activation levels and in IAP gene expres- sion[J]. Cancer Lett,2005 ; 224:53 -65.
  • 8Bava SV, Puliappadamba VT, Deepti A, et al. Sensitization of taxol - induced apoptosis by curcumin involves down - regulation of nuclear factor - kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization [ J ]. J Biol Chem, 2005 ; 280 : 6301 - 6308.
  • 9Chan MM, Fong D, Soprano KJ, et al. Inhibition of growth and sensitization to cisplatin - mediated killing of ovarian cancer ceils by polyphenolic ehemopreventive agents [ J ]. J Cell Physiol, 2003 ; 194:63 -70.
  • 10Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potenti- ates antitumor activity of gemcitabine in an orthotopic model of pan- creatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor - { kappa } B regulated gene products [J]. Cancer Res, 2007; 67:3853-3861.

共引文献154

同被引文献19

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1(2):70-76.
  • 2Sathomsumetee,S,Rich JN.New approaches to primary brain tumor treatment[J].Anticancer Drugs,2006,17 (9):1003-1016.
  • 3Liu F,Liu S,He S,et al.Survivin transcription is associated with P-plycoprotein /MDRI overexpression in the multidrug resistance of MCF-7 breast cancer cells[J].Oncol Rep,2010,23 (5):1469-1475.
  • 4Sathornsumetee S,Rich JN,Reardon DA.Diagnosis and treatment of high-grade astrocytoma[J].Neurol Clin,2007,25(4):111-1139.
  • 5Nobuhiro Mikuni,Susumu Miyamoto.Surgical treatment for glioma:extent of resection applying functional neurosurgery[J].Neurol Med Chir(Tokyo),2010,50:720-726.
  • 6Deorah S,Lynch CF,Slib ebenaller ZA,et al.Trends in brain cancer incidence and survival in the United States:Surveillance,Epidemiology,and End Resultes Program,1973 to 2001[J].Neurosurg Focus,2006,20(4):347-351.
  • 7Zustovich F,Lombardi G,Della Puppa A,et al.A phase Ⅱ study of cisplatin and temozolomide in heavily pretreated patients with temozolomide-refractory high-grade malignant glioma[J].Anticancer Res,2009,29 (10):4275-4279.
  • 8Natsume A,Ishii D,Wakabayashi T,et al.IFN-beta downregulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide[J].Cancer Res,2005,65(17):7573-7579.
  • 9Wen PY,Kesari S.Malignant gliomas in adults[J].N Engl J Med 2008,359(5):492-507.
  • 10Louis DN,Holland EC,Cairncross JG.Glioma classification:a molecular reappraisal[J].Am J Pathol,2001,159(3):779-786.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部